Next Article in Journal
Osteoarthritis Development Following Meniscectomy vs. Meniscal Repair for Posterior Medial Meniscus Injuries: A Systematic Review
Next Article in Special Issue
The Impact of COVID-19 Infection on Patients with Severe Chronic Pulmonary Hypertension: A Prospective Study from a Single Referral Center
Previous Article in Journal
Morphological Evaluation and Immunohistochemical Analysis of the Reparative Potential of the Buccal Fat Pad
Previous Article in Special Issue
Acquired Cardiovascular Diseases in Patients with Pulmonary Hypertension Due to Congenital Heart Disease: A Case Report
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 60
Issue 4
10.3390/medicina60040568
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia

by
Anna Krigere
1,
Verners Roberts Kalejs
1,
Ricards Kaulins
2,
Ainars Rudzitis
1,2,
Liga Bondare
1,
Matiss Sablinskis
1,
Aivars Lejnieks
2,3,
Dana Kigitovica
1,2,
Marcin Kurzyna
4 and
Andris Skride
1,2,*
1
Department of Rare Diseases, Pauls Stradins Clinical University Hospital, 1002 Riga, Latvia
2
Department of Internal Diseases, Riga Stradins University, 1007 Riga, Latvia
3
Department of Internal Diseases, Riga East Clinical University Hospital, 1038 Riga, Latvia
4
Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Center of Postgraduate Medical Education, ERN-LUNG Member, 05-400 Otwock, Poland
*
Author to whom correspondence should be addressed.
Medicina 2024, 60(4), 568; https://doi.org/10.3390/medicina60040568
Submission received: 14 January 2024 / Revised: 21 March 2024 / Accepted: 27 March 2024 / Published: 30 March 2024
(This article belongs to the Special Issue Pulmonary Hypertension: Symptoms, Diagnosis and Management)
Browse Figure
Versions Notes

Abstract

Background: Treatment options for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent pulmonary hypertension after pulmonary endarterectomy (PEA) include targeted medical therapy and balloon pulmonary angioplasty (BPA). BPA is an emerging treatment modality that has been reported to improve functional capacity, pulmonary hemodynamics, and right ventricular function. Reports from expert centers are promising, but more data are needed to make the results more generalizable. Materials and Methods: We conducted a prospective analysis of nine consecutive CTEPH patients who underwent balloon pulmonary angioplasty (BPA) sessions at Pauls Stradins Clinical University Hospital in Riga, Latvia between 1 April 2022 and 1 July 2023. We assessed World Health Organization (WHO) functional class, 6 min walk distance (6MWD), blood oxygen saturation (SpO2), brain natriuretic peptide (BNP) level at baseline and 3 months after the first BPA session. For two patients on whom repeated BPA sessions were performed, we additionally assessed cardiac output (CO), pulmonary vascular resistance (PVR), and mean pulmonary artery pressure (mPAP). Results: A total of 12 BPA procedures for nine patients were performed; repeated BPA sessions were performed for two patients. Our results show a reduction in BNP levels and improvement in WHO functional class, 6MWD, and SpO2 after the first BPA session. Improvement in 6MWD was statistically significant. Additionally, an improvement in pulmonary hemodynamic parameters was observed. Conclusions: Our data show that BPA is an effective interventional treatment modality, improving both the pulmonary hemodynamics and functional status. Moreover, BPA is safe and excellently tolerated.
Keywords: balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension; Latvia balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension; Latvia

Share and Cite

MDPI and ACS Style

Krigere, A.; Kalejs, V.R.; Kaulins, R.; Rudzitis, A.; Bondare, L.; Sablinskis, M.; Lejnieks, A.; Kigitovica, D.; Kurzyna, M.; Skride, A. The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia. Medicina 2024, 60, 568. https://doi.org/10.3390/medicina60040568

AMA Style

Krigere A, Kalejs VR, Kaulins R, Rudzitis A, Bondare L, Sablinskis M, Lejnieks A, Kigitovica D, Kurzyna M, Skride A. The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia. Medicina. 2024; 60(4):568. https://doi.org/10.3390/medicina60040568

Chicago/Turabian Style

Krigere, Anna, Verners Roberts Kalejs, Ricards Kaulins, Ainars Rudzitis, Liga Bondare, Matiss Sablinskis, Aivars Lejnieks, Dana Kigitovica, Marcin Kurzyna, and Andris Skride. 2024. "The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia" Medicina 60, no. 4: 568. https://doi.org/10.3390/medicina60040568

APA Style

Krigere, A., Kalejs, V. R., Kaulins, R., Rudzitis, A., Bondare, L., Sablinskis, M., Lejnieks, A., Kigitovica, D., Kurzyna, M., & Skride, A. (2024). The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia. Medicina, 60(4), 568. https://doi.org/10.3390/medicina60040568

Article Metrics

Back to TopTop